GILD · Gilead Sciences
Latest news, signals, and AI analysis for Gilead Sciences (GILD) on Catalayer. Updated continuously as stories are indexed across our news feed.
Recent GILD News
Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology Portfolio
Related Tickers
$JNJ · Johnson & Johnson$LLY · Eli Lilly$PFE · Pfizer$MRK · Merck$ABBV · AbbVie$NVO · Novo NordiskFrequently Asked Questions
What sector does GILD belong to?
GILD (Gilead Sciences) is classified under the Pharma sector on Catalayer. You can browse all news in this sector at /sector/pharma.
Where can I track real-time GILD news?
Catalayer aggregates GILD coverage from Reuters, Bloomberg, CNBC, MarketWatch, Yahoo Finance, Seeking Alpha, Barron’s, WSJ, Motley Fool, Benzinga, TipRanks and 20+ other sources. View the live feed at https://catalayer.com/stocks/GILD.
How fast are GILD news alerts on Catalayer?
News is polled every 30–60 seconds. GILD-related stories appear in your workspace within minutes of publication, and you can create a custom monitor to get instant alerts.
Does Catalayer provide AI analysis for GILD?
Yes. The Market Intelligence tier adds AI-powered event classification (monetary policy, earnings, guidance, M&A), directional impact (bullish/bearish), magnitude, and affected-sector analysis to every GILD story.
Is GILD covered in any Catalayer signal channels?
Signal channels and custom keyword monitors both support GILD. Free accounts get 1 monitor; Plus ($29/mo) unlocks 5 monitors with boolean rules across tickers, sectors, and topics.